UBS
UBS shares hit 18-year high ahead of Swiss capital rules vote
UBS stock rose 4.8% last week to CHF 44.53 as investors awaited a key Senate committee decision on stricter capital requirements. The debate centers on whether the bank must raise $20 billion in hard equity or may use cheaper AT1 bonds.
Swiss Market Index shifts to 40% pharma weight after latest rebalancing
Healthcare now dominates the SMI after recent additions, raising concentration concerns but offering diversification within the sector itself.
UBS ranks Switzerland’s most desirable residential locations
UBS study finds medium-sized Swiss cities outperform large urban centers on cost and livability, with Freiburg, Solothurn and Aarau leading in affordability. Nine of ten regions favor mid-sized towns over metropolises.
Partners Group Private Equity NAV drops 8.6% in H1 2026 as four assets weigh
Net asset value fell to EUR 11.57 per share as USIC, Emeria, Pharmathen and Ammega weighed on returns, though distributions remained robust at EUR 111 million.
Swiss SMI edges up 0.12% as Roche, Novartis weigh on blue chips
Amrize and Holcim lead gains in the SMI, while Stadler Rail surges 22% on strong half-year results. US PCE inflation ticks up to 3.7%, lifting September Fed hike odds to 40%.
VP Bank reports 1.4 bln CHF net new money inflow in H1, eyes Asia expansion
CEO Urs Monstein outlines turnaround progress, with net new money at 1.4 bln CHF in the first half and a focus on cost discipline, Asian growth and potential acquisitions. Cost/income ratio falls to 78.8%.
TWG working with regulators to cut affiliated insurance assets
Group 1001's insurers face scrutiny over related-party investments; TWG plans $6.5 billion swap to reduce exposure. Mark Walter denies fraud allegations.
Partners Group PE NAV falls 8.6% in H1 2026 as distributions rise
Private equity investor’s net asset value declined amid portfolio write-downs, though strong investor payouts and selective deployments provided partial offset. Shares trade at a 38.8% discount to NAV.
Swiss banker Pierre Mirabaud pleads guilty in Kuwait corruption case
Former Swiss Bankers Association president admits to money laundering and illicit commissions linked to Kuwaiti pension fund investments. Trial set for September 8.
UBS pushes for softer AT1 capital rules amid Swiss bank reform debate
Swiss lawmakers weigh compromise on Additional-Tier-1 debt as UBS-backed study argues for earlier loss-absorption triggers. Next vote set for Aug. 31.
Swiss stocks mixed as SMI edges higher; Arbonia plunges on earnings
ABB gains led gains among large caps while Arbonia slumped 9.8% after results; UBS and Vontobel adjusted ratings and price targets for several Swiss equities. The Swiss franc weakened further against the dollar and euro.
Swiss economic calendar: Aug 25–Sep 1, 2026
Half-year earnings reports from Swiss companies alongside key macroeconomic data releases and industry events next week.
Swiss stocks fall 1.1% as heavyweights weigh; Partners Group leads gains
Defensive Swiss equities lagged as the SMI slipped 1.1% to 14,384 amid profit-taking ahead of Jackson Hole. Partners Group surged 2.2% while Nestlé, Novartis and Roche declined.
Swiss SMI dips 1% as Nestlé, Novartis, Roche weigh; Gurit surges 10%
Heavyweights drag Switzerland’s blue-chip index lower while Gurit jumps on strong earnings. Investors eye Jackson Hole for Fed clues amid elevated inflation and geopolitical risks.
SNB insists on stricter capital rules for UBS despite parliamentary pushback
Swiss National Bank vice chair rejects compromise proposal to ease CET1 capital requirements for UBS, citing financial stability risks. Parliamentary committee expected to rule next week.
UBS study: Mid-sized Swiss cities more attractive for families than Zurich, Geneva
Lower living costs and strong infrastructure in smaller urban centers outweigh benefits of major cities, UBS research finds. Study examines 10 Swiss regions with a two-child family model.
Urner Kantonalbank posts 13.3% profit drop on Kamuno writedown
Swiss regional lender’s first-half profit fell to 8.9 million francs as a 13.3 million-franc Kamuno impairment offset growth in core lending and fee income.
Citi warns on European bank stock upside as sector rallies stall
Analysts at Citi downgrade outlook for European lenders despite strong 2026 gains, citing stretched valuations and ECB rate hike risks. HSBC, Santander and BNP Paribas among top performers.
Swiss stocks open higher as SMI gains 0.14% on mixed sector moves
SMI advances to 14,538 points with UBS and Amrize among top gainers, while Kühne+Nagel, Lonza and Alcon lag behind. Brent crude falls 2.5% to $86.35 amid Iran talks.
Swiss analyst confidence rises for second straight month: UBS CFA survey
The UBS CFA Indicator climbed 2.1 points to +12.1 in August, marking the second consecutive positive reading since geopolitical tensions flared. Analysts remain split on Swiss growth, while SNB rate expectations stay anchored near zero through mid-2027.
Swiss stocks end flat as ABB, pharma weigh; UBS, Vetropack rise
The SMI slipped 0.07% to 14,447 as investors took profits on ABB and sold off Roche and Novartis. UBS gained 1.7% and Vetropack surged 4.4% on company-specific news.
Swiss equities flat as SMI hovers near 14,464; Logitech, ABB rise; Amrize falls
The Swiss Market Index edges 0.11% higher as Nestlé weighs on blue chips, while Logitech and ABB gain ground. Mid-cap and small-cap segments show mixed performance amid corporate updates and ratings changes.
Siegfried shares fall 5.3% after UBS downgrade to Neutral
Swiss drugmaker’s stock drops to CHF 76 after UBS cuts rating and price target, citing slower-than-expected US business ramp-up and back-loaded 2026 growth concerns.
Swiss economic calendar: August 24-31, 2026
Over 30 Swiss companies and institutions to release half-year earnings and key economic data, including UBS-CFA Index, KOF barometer and SBB H1 results.